What is the typical starting dose of Haldol (haloperidol) for intramuscular (IM) administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Haloperidol IM Dosing

For acute agitation in adults, administer haloperidol 5 mg IM as the initial dose, which can be repeated every 20-30 minutes as needed, with a ceiling effect at 10-15 mg total dose beyond which efficacy diminishes. 1, 2, 3

Standard Adult Dosing Algorithm

Initial dose: 5 mg IM for acute agitation 1, 2, 3

Repeat dosing strategy:

  • Evaluate response at 15-30 minutes 2
  • If inadequate sedation, administer additional 5 mg IM 2
  • May repeat every 20-30 minutes until tranquilization achieved 2, 3
  • Critical ceiling effect: Maximum benefit occurs at 10-15 mg total dose—higher doses show diminishing returns and potentially decreased efficacy 1, 2
  • Maximum daily limit: 40 mg 3

FDA-approved dosing: The official label recommends 2-5 mg IM for prompt control of acutely agitated patients, with subsequent doses as often as every hour, though 4-8 hour intervals may be satisfactory 4. However, the more recent guideline evidence supports the 5 mg starting dose as optimal for most acute situations 1, 2.

Combination Therapy for Severe Agitation

If monotherapy inadequate after 30 minutes, consider combination approaches: 2

  • Haloperidol 5 mg + lorazepam 2 mg IM: Produces faster sedation than monotherapy 1, 2
  • Haloperidol + diphenhydramine: Reduces extrapyramidal symptoms 2
  • Haloperidol + midazolam: Alternative combination option 2

Special Population Dosing

Geriatric patients (≥65 years):

  • Start with 0.5-1 mg IM 5
  • Low-dose haloperidol (≤0.5 mg) demonstrates similar efficacy to higher doses in older adults with significantly better safety profile 5
  • Higher doses in elderly patients increase sedation risk without improving agitation control 6

Pediatric dosing: 7, 2, 3

  • Adolescents (13+ years): 2-5 mg IM, may repeat every 20-30 minutes 7, 2
  • Children (6-12 years): 0.5-2 mg IM 7, 2
  • Weight-based alternative: 0.1 mg/kg IM (maximum 5 mg per dose) 3
  • Maximum daily dose for pediatrics: 30 mg 3

Critical Safety Monitoring

Absolute contraindications: 2

  • Intoxication states 2
  • Anticholinergic delirium (may worsen condition) 2

Use with extreme caution in: 2

  • Respiratory compromise 2

Monitor for adverse effects:

  • Extrapyramidal symptoms (dystonia, akathisia): Occur in ~20% of patients, more common at higher cumulative doses and in young males 2, 3
  • QTc prolongation: Increased risk above 7.5 mg/day, monitor with repeated dosing 2, 3
  • Orthostatic hypotension: Particularly in unstable patients 2, 3
  • Respiratory depression: When combined with benzodiazepines 3

Common Pitfalls to Avoid

Overdosing trap: Despite guidelines recommending lower doses, clinicians frequently administer higher than recommended initial doses (>1 mg in elderly, >5 mg in adults), which increases adverse effects without improving efficacy 6. The evidence shows no benefit to exceeding 10-15 mg total dose 1, 2.

First-episode psychosis: Many patients respond to doses as low as 2 mg daily, with optimal doses well below common practice levels 8. Starting too high compromises future medication adherence due to extrapyramidal side effects 1.

Geriatric population: The recommended 0.5 mg starting dose is frequently ignored, with 37.5% of elderly patients receiving >1 mg initially in one study, resulting in higher sedation rates without improved outcomes 6.

References

Guideline

Haloperidol Dosing Guidelines for Schizophrenia and Acute Psychosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Haloperidol IM Dosing for Acute Agitation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Haloperidol Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Optimal haloperidol dosage in first-episode psychosis.

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.